Loading…
Expressing support for the protection of Medicare part D's six protected classes.
Legislative Progress
Introduced
September 22, 2022
Latest Action
September 23, 2022
Primary Sponsor
Grace F. NapolitanoDemocratic(CA)
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
58pct
1d open
vs 1,532 other HRES bills in the 117th — cohort avg 32d
This resolution expresses support for the six protected classes of prescription drugs under the Medicare prescription drug benefit: antidepressants, antipsychotics, anticonvulsants, immunosuppressants, antiretrovirals, and antineoplastics.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (3)
2023 · second_quarter · Health Issues
Inflation Reduction Act Medicare Part D 6 Protected Classes Executive Order on Drug Pricing H.R.5237, The Reduced Cost and Continued Cures Act S.3427, The Neuroscience Center of Excellence Act of 2021 Prescription Drug User Fees FDA Neurology Drug Program H.Res.1390, Expressing support for the protected class
Referred to the Subcommittee on Health.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Introduced in House
Congress.gov source codes: 1000, Intro-H
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: $340,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2023 · first_quarter · Health Issues
Inflation Reduction Act Medicare Part D 6 Protected Classes Executive Order on Drug Pricing H.R.5237, The Reduced Cost and Continued Cures Act S.3427, The Neuroscience Center of Excellence Act of 2021 Prescription Drug User Fees FDA Neurology Drug Program H.Res.1390, Expressing support for the protected class
Client expense: $200,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Health Issues
Inflation Reduction Act Medicare Part D 6 Protected Classes Executive Order on Drug Pricing S. 2327, Seniors Prescription Drug Relief Act H.R.5237, The Reduced Cost and Continued Cures Act H.R.6000, the CURES 2.0 Act S.3427, The Neuroscience Center of Excellence Act of 2021 Prescription Drug User Fees FDA Neurology Drug Program H.Res.1390, Expressing support for the protected class
Client expense: $360,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Medicare/Medicaid
Policies to enhance patient access to medicines in Medicaid including rebate, waiver policy and funding issues; Policies to enhance patient access to medicines in Medicare; Discussions related to rebates and Medicare part D - provisions related to the HHS-OIG Rebate Safe Harbor; Proposals related to amending the protected classes in Medicare; H. Res. 1390, Expressing Support for the Six Medicare Protected Class; Medicare payment proposals; Medicare telehealth proposals; IVIG Medicare demonstration project; CMS Medicaid Value Based Purchasing Final Rule (CMS 2482-F); P.L. 117-169 Inflation Reduction Act - reconciliation package with provisions related to prescription drug prices, implementation, negotiation, Part D redesign, inflation penalties; Implementation 2023 Physician Fee Schedule rule related to Part B discarded drug policy; H.R. 4941, PACE Part D Choice Action of 2021 - provisions related to Medicare PDP;
Client expense: $780,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, White House Office
2022 · fourth_quarter · Medicare/Medicaid
Drug Pricing Issues: H.R. 5376, Inflation Reduction Act of 2022; Nursing Home Quality: S. 4659, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2023; Parkinson's Plan: S. 4851, National Plan to End Parkinsons Act; Six Protected Classes resolution: H. Res. 1390, Expressing support for the protection of Medicare part D's six protected classes
Client expense: $370,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Medicare/Medicaid
Drug Pricing Issues: H.R. 5376, Inflation Reduction Act of 2022; Nursing Home Quality: S. 4659, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2023; Parkinson's Plan: S. 4851, National Plan to End Parkinsons Act; Six Protected Classes resolution: H. Res. 1390, Expressing support for the protection of Medicare part D's six protected classes
Client expense: $370,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Medicare/Medicaid
Policies to enhance patient access to medicines in Medicaid including rebate, waiver policy and funding issues; Policies to enhance patient access to medicines in Medicare; Discussions related to rebates and Medicare part D - provisions related to the HHS-OIG Rebate Safe Harbor; Proposals related to amending the protected classes in Medicare; H. Res. 1390 Expressing Support for the Six Medicare Protected Class; Medicare payment proposals; Medicare telehealth proposals; CMS Transparency in Coverage Final Rule (CMS-9915-F); CMS Medicaid Value Based Purchasing Final Rule (CMS 2482-F); P.L. 117-169 Inflaction Reduction Act - reconciliation package with provisions related to prescription drug prices and implementation issues; H.R. 7389 MVP Act; Implementation 2023 Physician Fee Schedule rule related to Part B discarded drug policy;
Client expense: $1,580,000 · Firm income: Not reported
2022 · third_quarter · Medicare/Medicaid
Drug Pricing Issues: H.R. 5376, Inflation Reduction Act of 2022; Nursing Home Quality: S. 4659, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2023; Parkinson's Plan: S. 4851, National Plan to End Parkinsons Act; Six Protected Classes resolution: H. Res. 1390, Expressing support for the protection of Medicare part D's six protected classes
Client expense: $260,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
| Democratic |
| CA |
| Betty McCollum | Democratic | MN |
| Bill Pascrell, Jr. | Democratic | NJ |
| Brian K. Fitzpatrick | Republican | PA |
| Darren Soto | Democratic | FL |
| David J. Trone | Democratic | MD |
| Doris O. Matsui | Democratic | CA |
| Grace Meng | Democratic | NY |
| James P. McGovern | Democratic | MA |
| Jenniffer González-Colón | Republican | PR |
| John Katko | Republican | NY |
| Lucille Roybal-Allard | Democratic | CA |
| Mikie Sherrill | Democratic | NJ |
| Nydia M. Velázquez | Democratic | NY |
| Paul Tonko | Democratic | NY |
| Pete Aguilar | Democratic | CA |
| Raja Krishnamoorthi | Democratic | IL |
| Raúl M. Grijalva | Democratic | AZ |
| Tony Cárdenas | Democratic | CA |
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE